These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22177408)

  • 41. Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors.
    Chen YH; Zhang YH; Zhang HJ; Liu DZ; Gu M; Li JY; Wu F; Zhu XZ; Li J; Nan FJ
    J Med Chem; 2006 Mar; 49(5):1613-23. PubMed ID: 16509578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.
    Carland JE; Handford CA; Ryan RM; Vandenberg RJ
    Neurochem Int; 2014 Jul; 73():211-6. PubMed ID: 24036283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities.
    Demirbas A; Sahin D; Demirbas N; Karaoglu SA
    Eur J Med Chem; 2009 Jul; 44(7):2896-903. PubMed ID: 19167136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological activity of pyrazolothienotetrahydroisoquinoline and [1,2,4]triazolo[3,4-a]thienotetrahydroisoquinoline derivatives.
    Kamal AM; Radwan SM; Zaki RM
    Eur J Med Chem; 2011 Feb; 46(2):567-78. PubMed ID: 21185109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors.
    Pinard E; Alberati D; Bender M; Borroni E; Brom V; Burner S; Fischer H; Hainzl D; Halm R; Hauser N; Jolidon S; Lengyel J; Marty HP; Meyer T; Moreau JL; Mory R; Narquizian R; Norcross RD; Schmid P; Wermuth R; Zimmerli D
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6960-5. PubMed ID: 20974532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
    Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.
    Uslaner JM; Drott JT; Sharik SS; Theberge CR; Sur C; Zeng Z; Williams DL; Hutson PH
    Behav Brain Res; 2010 Feb; 207(1):37-43. PubMed ID: 19799936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.
    Mostyn SN; Carland JE; Shimmon S; Ryan RM; Rawling T; Vandenberg RJ
    ACS Chem Neurosci; 2017 Sep; 8(9):1949-1959. PubMed ID: 28574249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities.
    Bayrak H; Demirbas A; Karaoglu SA; Demirbas N
    Eur J Med Chem; 2009 Mar; 44(3):1057-66. PubMed ID: 18676062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord.
    Raiteri L; Stigliani S; Usai C; Diaspro A; Paluzzi S; Milanese M; Raiteri M; Bonanno G
    Neurochem Int; 2008 Jan; 52(1-2):103-12. PubMed ID: 17597258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors.
    Navidpour L; Shafaroodi H; Abdi K; Amini M; Ghahremani MH; Dehpour AR; Shafiee A
    Bioorg Med Chem; 2006 Apr; 14(8):2507-17. PubMed ID: 16337127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional 'glial' GLYT1 glycine transporters expressed in neurons.
    Raiteri L; Raiteri M
    J Neurochem; 2010 Aug; 114(3):647-53. PubMed ID: 20477934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain.
    Hermanns H; Muth-Selbach U; Williams R; Krug S; Lipfert P; Werdehausen R; Braun S; Bauer I
    Neurosci Lett; 2008 Nov; 445(3):214-9. PubMed ID: 18793697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
    Woo LW; Jackson T; Putey A; Cozier G; Leonard P; Acharya KR; Chander SK; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2010 Mar; 53(5):2155-70. PubMed ID: 20148564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycine transporters: essential regulators of synaptic transmission.
    Betz H; Gomeza J; Armsen W; Scholze P; Eulenburg V
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):55-8. PubMed ID: 16417482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and semisynthesis of novel fredericamycin A derivatives with an improved antitumor profile.
    Abel U; Simon W; Eckard P; Hansske FG
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3292-7. PubMed ID: 16621542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of [(3)H]glycine release from mouse spinal cord synaptosomes selectively labeled through GLYT2 transporters.
    Luccini E; Raiteri L
    J Neurochem; 2007 Dec; 103(6):2439-48. PubMed ID: 17944872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.